These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 22195757
1. Update on laboratory tests for the diagnosis and differentiation of hereditary angioedema and acquired angioedema. Frazer-Abel A, Giclas PC. Allergy Asthma Proc; 2011; 32 Suppl 1():17-21. PubMed ID: 22195757 [Abstract] [Full Text] [Related]
4. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting. Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I. Int Arch Allergy Immunol; 2014 Nov 01; 165(2):119-27. PubMed ID: 25401373 [Abstract] [Full Text] [Related]
6. Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema. Bork K, Witzke G. Int Arch Allergy Immunol; 2016 Nov 01; 170(2):101-7. PubMed ID: 27463190 [Abstract] [Full Text] [Related]
12. Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization. Christiansen SC, Zuraw BL. Immunol Allergy Clin North Am; 2024 Aug 01; 44(3):543-560. PubMed ID: 38937015 [Abstract] [Full Text] [Related]
13. Genetic test indications and interpretations in patients with hereditary angioedema. Weiler CR, van Dellen RG. Mayo Clin Proc; 2006 Jul 01; 81(7):958-72. PubMed ID: 16835976 [Abstract] [Full Text] [Related]
14. Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. Wagenaar-Bos IG, Drouet C, Aygören-Pursun E, Bork K, Bucher C, Bygum A, Farkas H, Fust G, Gregorek H, Hack CE, Hickey A, Joller-Jemelka HI, Kapusta M, Kreuz W, Longhurst H, Lopez-Trascasa M, Madalinski K, Naskalski J, Nieuwenhuys E, Ponard D, Truedsson L, Varga L, Nielsen EW, Wagner E, Zingale L, Cicardi M, van Ham SM. J Immunol Methods; 2008 Sep 30; 338(1-2):14-20. PubMed ID: 18655790 [Abstract] [Full Text] [Related]
16. Hereditary Angioedema With Normal C1 Inhibitor: US Survey of Prevalence and Provider Practice Patterns. Riedl MA, Danese M, Danese S, Ulloa J, Maetzel A, Audhya PK. J Allergy Clin Immunol Pract; 2023 Aug 30; 11(8):2450-2456.e6. PubMed ID: 36720386 [Abstract] [Full Text] [Related]
18. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. Busse P, Kaplan A. J Allergy Clin Immunol Pract; 2022 Mar 30; 10(3):716-722. PubMed ID: 34838707 [Abstract] [Full Text] [Related]
19. Clinical and laboratory characteristics that differentiate hereditary angioedema in 72 patients with angioedema. Ohsawa I, Honda D, Nagamachi S, Hisada A, Shimamoto M, Inoshita H, Mano S, Tomino Y. Allergol Int; 2014 Dec 30; 63(4):595-602. PubMed ID: 25249065 [Abstract] [Full Text] [Related]
20. The US Hereditary Angioedema Association Scientific Registry: hereditary angioedema demographics, disease severity, and comorbidities. Christiansen SC, Wilmot J, Castaldo AJ, Zuraw BL. Ann Allergy Asthma Immunol; 2023 Dec 30; 131(6):766-774.e8. PubMed ID: 37619776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]